Related Experiment Video
Updated: Dec 10, 2025

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
Autonomic Changes in Juvenile-Onset Huntington's Disease
Jordan L Schultz1,2, Peg C Nopoulos1,2,3
1Department of Psychiatry, Carver College of Medicine at the University of Iowa, Iowa City, IA 52242, USA.
Juvenile-onset Huntington's Disease (JOHD) is linked to autonomic nervous system changes. Early JOHD increases resting heart rate, while later stages affect blood pressure, suggesting neurodegeneration impacts the brain-heart axis.
Area of Science:
- Neurology
- Autonomic Neuroscience
- Pediatric Neurology
Background:
- Adult-onset Huntington's Disease (AOHD) involves autonomic nervous system (ANS) dysfunction, linked to neurodegeneration and brain-heart axis disruption.
- This relationship remains unexplored in juvenile-onset Huntington's Disease (JOHD).
Purpose of the Study:
- To compare physiological autonomic measures between JOHD patients and controls.
- To investigate the impact of disease progression on these measures in JOHD.
Main Methods:
- Utilized data from the Kids-JOHD study, comparing JOHD patients (n=27) with gene-expansion-negative controls (GNE group, n=259).
- Measured resting heart rate (rHR), systolic blood pressure (SBP), and diastolic blood pressure (DBP).
- Employed linear mixed-effects models, controlling for covariates and accounting for participant/family clustering.
Main Results:
- JOHD patients exhibited significantly higher rHR compared to controls.
- JOHD patients showed significantly lower SBP than controls; DBP was also lower but not significant.
- SBP and DBP decreased with longer disease duration in JOHD, while rHR did not further increase.
Conclusions:
- Elevated rHR in early JOHD suggests central autonomic network neurodegeneration.
- Later decreases in SBP/DBP may indicate brainstem neurodegeneration (e.g., medulla).
- rHR appears more sensitive than blood pressure to early autonomic changes in JOHD.
Related Concept Videos
Parkinson's Disease: Overview
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Hypertension II: Pathophysiology

